According to this approach, it has been demonstrated that shRNA‐mediated targeted downregulation of system Xc (xCT or SLC7A11) reduces extracellular glutamate levels, leading to decreased invasion of GBM cells. The gene discussed is SLC7A11; the disease is glioblastoma.